Transjugular Intrahepatic Portosystemic Shunt (TIPS): Title and subTitle BreakDiagnostic and Therapeutic Technology Assessment (DATTA) FREE

Robin Miller-Catchpole, MD

[+] Author Affiliations

Edited by Helene M. Cole, MD, Contributing Editor.

This report is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all of the facts and circumstances involved in an individual case and are subject to change as scientific knowledge and technology advance and practice patterns evolve.

Inquiries regarding this DATTA report should be submitted to Department of Technology Assessment, American Medical Association, 515 N State St, Chicago, IL 60610 (Sona Kalousdian, MD, MPH).

JAMA. 1995;273(23):1824-1830. doi:10.1001/jama.1995.03520470032014

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

Objective. —To provide clinicians with a technology assessment of the safety and effectiveness of the use of a transjugular intrahepatic portosystemic shunt (TIPS) for reducing portal hypertension and its associated complications of esophageal varices and ascites.

Participants. —A literature review and a Diagnostic and Therapeutic Technology Assessment (DATTA) survey questionnaire were mailed to 72 physicians with expertise in gastrointestinal or abdominal surgery or interventional radiology and a special interest in liver disease or esophageal varices. These panelists had been nominated to the DATTA panel by appropriate specialty societies and medical schools. A total of 54 panelists (75%) responded.

Evidence. —Assessment was based on the expert opinion of the panelists, as well as on published scientific literature (available as of January 2, 1995). Published studies were identified by a MEDLINE search using the terms transjugular intrahepatic portosystemic shunt, TIPS, and transjugular and by review of the references cited in these primary sources.

Consensus Process. —The respondents completed a DATTA survey questionnaire; the survey results were tabulated, analyzed, and interpreted by an American Medical Association staff physician.

Conclusions. —The safety of TIPS was considered to be established in the acute control of bleeding from esophageal varices in patients who had failed sclerotherapy. The safety of TIPS was considered to be promising for long-term control of bleeding from esophageal varices. In patients with end-stage liver disease and esophageal varices who are liver transplant candidates, the use of TIPS was considered to be an established therapy. The effectiveness of TIPS was considered to be (1) established in the acute control of bleeding in patients who failed sclerotherapy; (2) promising for long-term control of bleeding from esophageal varices; and (3) established in patients with end-stage liver disease and esophageal varices who are candidates for liver transplants.(JAMA. 1995;273:1824-1830)

REFERENCES

ABSTRACT | REFERENCES

LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology . 1993;;187:413-420.

Cello JP, Grendell H, Crass RA, Trunkey DD, Cobb EE, Heilbron DC. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med . 1984;;311:1589-1594.

Ring EJ, Lake JR, Roberts JP, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med . 1992;;116:304-309.

Freeman RB, Fitz-Maurice SE, Greenfield AE, et al. Is the transjugular intrahepatic portacaval shunt procedure beneficial for liver transplant recipients? Transplantation . 1994;;58:297-300.

Terblanche J. Portal hypertension management. Surg Endosc . 1993;;7:472-478.

Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology . 1969;;92:1112-1114.

Colapinto RF, Stronell RD, Birch SJ, et al. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J . 1982;;126:267-268.

Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR Am J Roentgenol . 1985;; 145:821-825.

Rösch J, Uchida BT, Putnam JS, Buschman RW, Law RD, Hershey AL. Experimental intrahepatic portacaval anastomosis: use of expandable Gianturco stents. Radiology . 1987;;162:481-485.

Palmaz JC, Garcia F, Sibbitt RR, et al. Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension. AJR Am J Roentgenol . 1986;;147: 1251-1254.

Richter GM, Noeldge G, Palmaz JC, et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology . 1990;;174:1027-1030.

Zemel G, Becker GJ, Bancroft JW, Benenati JF, Katzen BT. Technical advances in transjugular intrahepatic portosystemic shunts. Radiographics . 1992;;12:615-622.

Zemel G, Katzen BT, Becker GJ, Benenati JF, Sallee S. Percutaneous transjugular portosystemic shunt. JAMA . 1991;;266:390-393.

Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med . 1994;;330:165-171.

Valji K, Bookstein JJ, Roberts AC, Oglevie SB, Royster AP, Varney RR. Overdilation of the Wallstent to optimize portal decompression during transjugular intrahepatic portosystemic shunt placement. Radiology . 1994;;191:173-176.

Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology . 1994;;106:1277-1283.

Rogers CG Jr, Paolini RM, O'Leary JP. Intrahepatic vascular shunting for portal hypertension: early experience with the transjugular intrahepatic portosystemic shunt. Am Surg . 1994;;60:114-117.

Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg . 1993;;165:566-571.

Chong WK, Malisch TA, Mazer MJ, Lind CD, Worrell JA, Richards WO. Transjugular intrahepatic portosystemic shunt: US assessment with maximum flow velocity. Radiology . 1993;;189:789-793.

Maynar M, Cabrera J, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt: early experience with a flexible trocar/catheter system. AJR Am J Roentgenol . 1993;;161:301-306.

Martin M, Zajko AB, Orons PD, et al. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery . 1993;;114:719-727.

Haskal ZJ, Ring EJ, LaBerge JM, et al. Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension. Radiology . 1992;;185:813-817.

Child CG III, Turcotte J. The Liver and Portal Hypertension: Major Problems in Clinical Surgery . Philadelphia, Pa: WB Saunders Co; 1984;.

Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology . 1994;;19:129-132.

Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics . 1993;;13:1185-1210.

Sanyal AJ, Freedman AM, Purdum PP. TIPS-associated hemolysis and encephalopathy. Ann Intern Med . 1992;;117:443-444.

Haskal ZJ, Pentecost MJ, Rubin RA. Hepatic arterial injury after transjugular intrahepatic portosystemic shunt placement: report of two cases. Radiology . 1993;; 188:85-88.

Lim HL, Abbitt PL, Kniffen JC, Myers BM. Hepatic infarction complicating a transjugular intrahepatic portosystemic shunt. Am J Gastroenterol . 1993;;88:2095-2097.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal